2017 Peru Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies, Innovative Technologies, Instrumentation, Opportunities

January 2017 | 1120 pages | ID: 2D1AB3CE1DAEN
Venture Planning Group

Abstracts

This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.

Highlights

• Five-year test volume and sales forecasts
• Feature comparison of major analyzers
• Profiles of market players and start-up firms developing innovative technologies and products
• Specific product and business opportunities for instrument and consumable suppliers

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Market Segmentation Analysis

• Five-year test volume and sales forecasts for major applications, including:
• Infectious Diseases
• Forensic Testing
• Cancer
• Paternity Testing/HLA Typing
• Genetic Diseases
• Others
• Five-year test volume and sales projections for over 30 NAT assays.

Product/Technology Review

• Comparison of leading molecular diagnostic analyzers.
• Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:
• PCR
• bDNA
• SDA
• NASBA
• TMA
• SSSR, and others
• LCR
• Companies, universities and research centers developing new molecular- diagnostic technologies and products.

Competitive Assessments

• Strategic profiles of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

Opportunities and Strategic Recommendations

• New product development opportunities with potentially significant market appeal during the next five years.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.
• Business planning issues and concerns.

Contains 1,120 pages and 48 tables

Contents

I. INTRODUCTION

II. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

A. Instrumentation
B. Reagent Kits and Test Systems/panels
C. Computers, Software and Automation
D. Auxiliary Products

III. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

VI. MOLECULAR DIAGNOSTIC TECHNOLOGY REVIEW

A. DNA Sequencing
B. DNA and RNA Probe Technologies
C. Detection Technologies
D. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
E. Pharmacogenomics
F. Competing/complementing
  1. MONOCLONAL ANTIBODIES/IMMUNOASSAYS
  2. RNA PROBES
  3. TWO-DIMENSIONAL ELECTROPHORESIS
  4. FLOW CYTOMETRY

VII. MOLECULAR DIAGNOSTIC INSTRUMENTATION REVIEW

VIII. MAJOR APPLICATIONS

1. MICROBIOLOGY/INFECTIOUS DISEASES
  a. Overview
  b. Major Infectious Diseases
    AIDS/HIV
    Adenovirus
    Aeromonads
    Anthrax/Bacillus Anthracis
    Arboviruses
    Babesiosis
    Bacillary Epithelioid Angiomatosis (BEA), other Bartonella (Rochalimaea)
    Blastocystis Hominis
    Brucella
    Campylobacter
    Candida
    Chagas Disease
    Chancroid
    Chlamydia
    Clostridium Difficile
    Coronaviruses
    Coxsackieviruses
    Creutzfeldt-Jakob’s Disease
    Cryptosporidium Parvum
    Cyclospora Cayetanensis
    Cytomegalovirus
    Ebola Virus
    E. Coli
    Echovirus
    Encephalitis
    Enteroviruses
    Epstein-Barr Virus
    Giardia Lamblia
    Gonorrhea
    Granuloma Inguinale
    Hantavirus
    Helicobacter Pylori
    Hepatitis
    Herpes Simplex Virus
    Human Herpes Virus-6 (HHV-6)
    Influenza Viruses
    Legionella
    Lyme Disease
    Lymphogranuloma Venereum (LGV)
    Malaria
    Measles (Rubeola)
    Meningitis
    Microsporidium
    Mononucleosis
    Mumps
    Mycoplasma
    Papillomaviruses
    Parvovirus B19
    Pneumonia
    Polyomaviruses
    Pseudomonas Aeruginosa
    Rabies
    Respiratory Syncytial Virus (RSV)
    Rhinoviruses
    Rotavirus
    Rubella
    Salmonellosis
    Septicemia
    Shigellosis
    Staphylococcus Aureus
    Streptococci
    Syphilis
    Toxoplasmosis
    Trichomonas Vaginalis
    Tuberculosis
    Vibrio
    West Nile Virus
    Yersinia
2. CANCER TESTING
  a. Overview
  b. Major Cancer Types
    Prostate
    Lung
    Colon and Rectum
    Breast
    Skin
    Uterine
    Leukemia
    Oral
  c. Oncogenes
    Abl/abl-bcr
    AIB1
    BCL-2
    BRCA1
    CD44
    C-fos
    C-myb
    C-myc
    CYP17
    Erb-B
    HPC1
    N-myc
    P40
    P51
    P53
    PIK3CA
    PTI-1
    Ras
    Reg
    Sis
    Src
3. GENETIC DISEASES
  a. Overview
  b. Nucleic Acid Amplification
  c. Chromosome Imaging
  d. Genomics Technologies
  e. Proteomics Technologies
  f. Current Pharmacogenomic Tests
  g. Future Pharmacogenomic Testing
  h. Major Diseases
    Achondroplasia
    Autosomal Dominant Polycystic Kidney Disease
    Cancer
    Cosmetogenomics
    Cystic Fibrosis
    Down's Syndrome
    Duchenne and Becker Muscular Dystrophy
    Factor V (Leiden)
    Factor IX Deficiency
    Fragile X Syndrome
    Heart Disease
    Hemochomatosis
    Hemophilia
    Huntington's Disease
    Maternal-Fetal Incompatibility
    Multiple Endocrine Neoplasia
    Phenylketonuria (PKU)
    Polycystic Kidney Disease (PKD)
    Prenatal Screening
    Retinitis Pigmentosa
    Retinoblastoma
    Sickle Cell Anemia
    Spinal Muscular Atrophy
    Vitamin B12 Metabolism
  i. Social Issues and Concerns
4. FORENSIC TESTING
  a. Overview
  b. Multilocus and Single Locus Probes
    Multilocus Probes
    Single Locus Probes
    PCR and RFLP
  c. DNA Profile Data Banks
  d. Judicial Implementation
  e. Major Crime Categories
  f. Factors Contributing to the DNA Probe Market Expansion
    Technology Availability
    Use of Hair as Evidence
  g. Wildlife Forensics
5. PATERNITY TESTING/HLA TYPING
6. OTHER APPLICATIONS
  a. Disease Susceptibility Testing
  b. Cardiovascular Diseases
  c. Diabetes
  d. Alzheimer's Disease
  e. Periodontal Disease
  f. Plasma Purification
  g. Organ Transplantation
  h. Water Contamination
  i. Other

IX. MARKET SIZE AND GROWTH: TEST VOLUME AND SALES FORECASTS

X. COMPETITIVE ASSESSMENTS

Abbott
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
CellMark Forensics/LabCorp
Cepheid
Decode Genetics
Diadexus
Eiken
Elitech Group
Enzo
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
Kreatech/Leica
Li-Cor Biosciences
Monogram Biosciences/LabCorp
Myriad Genetics
Ortho-Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher/Affymetrix

XI. APPENDIX: RESEARCH CENTERS DEVELOPING NEW TECHNOLOGIES AND PRODUCTS

List Of Tables

LIST OF TABLES

Molecular Diagnostics Test Volume and Sales Forecasts by Major Application
Molecular Diagnostics Test Volume by Major Application
Major Infectious Disease Test Volume by Assay
Major Infectious Disease Test Volume by Method
Molecular Diagnostics Market by Major Application
Major Infectious Disease Diagnostics Market by Assay
Major Companies Developing or Marketing Salmonella Molecular Diagnostic Tests
Major Companies Developing or Marketing AIDS Molecular Diagnostic Tests
Major Companies Developing or Marketing Adenovirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Bartonella Molecular Diagnostic Tests
Major Companies Developing or Marketing Campylobacter Molecular Diagnostic Tests
Major Companies Developing or Marketing Candida Molecular Diagnostic Tests
Major Companies Developing or Marketing Chlamydia Molecular Diagnostic Tests
Major Companies Developing or Marketing Clostridium Molecular Diagnostic Tests
Major Companies Developing or Marketing Coronavirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Cryptosporidium Molecular Diagnostic Tests
Major Companies Developing or Marketing CMV Molecular Diagnostic Tests
Major Companies Developing or Marketing Echovirus Molecular Diagnostic tests
Major Companies Developing or Marketing Enterovirus Molecular Diagnostic tests
Major Companies Developing or Marketing EBV Molecular Diagnostic Tests
Major Companies Developing or Marketing Giardia Molecular Diagnostic Tests
Major Companies Developing or Marketing Gonorrhea Molecular Diagnostic Tests
Major Companies Developing or Marketing Hantavirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Helicobacter Molecular Diagnostic Tests
Major Companies Developing or Marketing Hepatitis Molecular Diagnostic Tests
Major Companies Developing or Marketing Herpes Molecular Diagnostic Tests
Major Companies Developing or Marketing Influenza Molecular Diagnostic Tests
Major Companies Developing or Marketing Legionella Molecular Diagnostic Tests
Major Companies Developing or Marketing Lyme Disease Molecular Diagnostic Tests
Major Companies Developing or Marketing Measles Molecular Diagnostic Tests
Major Companies Developing or Marketing Meningitis Molecular Diagnostic Tests
Major Companies Developing or Marketing Mononucleosis Molecular Diagnostic Tests
Major Companies Developing or Marketing Mumps Molecular Diagnostic Tests
Major Companies Developing or Marketing Mycoplasma Molecular Diagnostic Tests
Major Companies Developing or Marketing Pneumonia Molecular Diagnostic Tests
Major Companies Developing or Marketing RSV Molecular Diagnostic Tests
Major Companies Developing or Marketing Rotavirus Molecular Diagnostic Tests
Major Companies Developing or Marketing Rubella Molecular Diagnostic Tests
Major Companies Developing or Marketing Septicemia Molecular Diagnostic Tests
Major Companies Developing or Marketing Shigella Molecular Diagnostic Tests
Major Companies Developing or Marketing Streptococci Molecular Diagnostic Tests
Major Companies Developing or Marketing Syphilis Molecular Diagnostic Tests
Major Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic Tests
Major Companies Developing or Marketing Trichomonas Molecular Diagnostic Tests
Major Companies Developing or Marketing Tuberculosis Molecular Diagnostic Tests
Oncogenes Potential Application in Cancer Diagnosis
Major Companies Developing or Marketing Cancer Molecular Diagnostic Tests
Major Companies Developing or Marketing Molecular Diagnostic Tests For Genetic Diseases